Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05069662

NCT05069662
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You must be 18 years old or older
  • You must be an outpatient (not admitted to hospital) who is taking cancer treatment in pill or capsule form and is part of the ONCORAL program, which provides specialist support for people on oral cancer medicines
  • You must have taken part in remote monitoring (such as phone or online check-ins) during the COVID-19 lockdown period between March 16, 2020 and May 11, 2020
  • You must be willing to allow your information to be used for this study and not object to taking part in the survey

Who may not be able to join:

  • You may not be able to join if you do not speak French
  • You may not be able to join if you currently live in a care home or other residential institution
  • You may not be able to join if you are legally protected (for example, under guardianship or a similar legal arrangement) (confirm with trial site)
  • You may not be able to join if you are already taking part in a clinical trial for a medication
  • You may not be able to join if you do not wish to take part, do not respond to two phone calls made to invite you to join, or do not answer any of those calls
  • You may not be able to join if you choose to stop the interview before it is completed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Hospices Civils de Lyon
Registry
clinicaltrials_gov
Start date
5 October 2021
Est. completion
5 January 2022

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Percentage of patients reporting a change in drug use during the COVID-19 pandemic-related containment period.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov